Arbet-Engels Christophe 4
4 · X4 Pharmaceuticals, Inc · Filed Sep 5, 2023
Insider Transaction Report
Form 4
Arbet-Engels Christophe
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2023-08-31$1.28/sh+1,250,000$1,600,000→ 1,250,000 totalExercise: $1.28Exp: 2033-08-30→ Common Stock (1,250,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option shall vest on August 31, 2024, with the remainder vesting in equal installments of 2.0833% of the shares subject to the option each successive month thereafter for a period of 36 months, subject to the Reporting Person continuing to provide services through each such date.